Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02487654
NA

Ectopy Triggering Ganglionated Plexus Ablation to Prevent Atrial Fibrillation

Sponsor: Imperial College London

View on ClinicalTrials.gov

Summary

Atrial fibrillation (AF) is a common heart rhythm disorder which can significantly affect a patient's quality of life and cause strokes. Abnormal electrical activity from the pulmonary veins are thought to be the most common cause of this condition. Current ablative strategy in drug refractory AF is pulmonary vein isolation (PVI), where the pulmonary veins are electrically isolated from the body of the left atrium. However, success rate of this procedure remain \~50-70% for a single procedure despite advances in mapping and ablation techniques. Ganglionated plexuses (GP) are dense clusters of nerves in the atria that are implicated in AF. Endocardial high frequency stimulation (HFS) delivered within the local atrial refractory period can trigger ectopy and AF from specific GP sites (ET-GP). The aim of this study was to understand the role of ET-GP ablation in the treatment of AF by comparing two different strategies: 1. Pulmonary vein isolation alone 2. GP ablation alone

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

116

Start Date

2017-12-01

Completion Date

2024-10-23

Last Updated

2024-09-23

Healthy Volunteers

No

Interventions

PROCEDURE

Pulmonary vein isolation

Conventional endocardial radiofrequency catheter ablation for pulmonary vein isolation.

PROCEDURE

Ganglionated plexus ablation

Endocardial radiofrequency catheter ablation of ganglionated plexus in the left atrium

Locations (3)

Hammersmith Hospital

London, United Kingdom

St Bartholomew's Hospital

London, United Kingdom

Derriford Hospital

Plymouth, United Kingdom